Patents by Inventor Pierre Bruhns

Pierre Bruhns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12059457
    Abstract: An immunogenic product including a cytokine conjugated with a carrier protein, wherein the cytokine is selected from the group including IL-4, IL-13 and mixtures thereof, and wherein the carrier protein is CRM197. Further, a method for manufacturing the immunogenic product. Also, the therapeutic use of the immunogenic product for treating an inflammatory disorder associated with aberrant IL-4 and/or IL-13 expression or activity.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: August 13, 2024
    Assignees: NEOVACS, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), INSTITUT PASTEUR
    Inventors: Géraldine Grouard-Vogel, Eva Conde García, Romain Bertrand, Noémie Caillot, Laurent Reber, Pierre Bruhns, Vincent Serra
  • Publication number: 20100028263
    Abstract: Lactobacillus compositions, especially those based on L. casei, and methods for the prevention and treatment of diseases or disorders involving or mediated by mast cells, such as anaphylaxis, allergy, autoimmune and inflammatory disorders including arthritis and rheumatoid arthritis.
    Type: Application
    Filed: August 3, 2009
    Publication date: February 4, 2010
    Applicants: INSTITUT PASTEUR, INSTITUT NATIONAL DE LA SANTE ET
    Inventors: Cecile Schiffer-Mannioui, Marc Daeron, Pierre Bruhns